Results 201 to 210 of about 112,374 (313)

Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction

, 2016
Jane A. Cannon, Li Shen, Pardeep S. Jhund, Søren Lund Kristensen, Lars Køber, Fabian Chen, Jianjian Gong, Martin Lefkowitz, Jean L. Rouleau, Victor Shi, Karl Swedberg, Michael R. Zile, Scott D. Solomon, Milton Packer, John J.V. McMurray   +14 more
openalex   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Prognostic value of lipid accumulation product in patients with type 2 diabetes mellitus and heart failure with reduced ejection fraction: a retrospective cohort study. [PDF]

BMC Res Notes
Wang H, Ma X, Zhang D, Liu S, Ma X, Zhao X.   +5 more
europepmc   +1 more source

Time-Adaptive Machine Learning Models for Predicting the Severity of Heart Failure with Reduced Ejection Fraction. [PDF]

Diagnostics (Basel)
Winger T, Ozdemir C, Narasimhan SL, Srivastava J.   +3 more
europepmc   +1 more source

Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction

, 2016
Gregory D. Lewis, Marc J. Semigran, Michael M. Givertz, Rajeev Malhotra, Kevin J. Anstrom, Adrian F. Hernandez, Monica Shah, Eugene Braunwald   +7 more
openalex   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Heart Rate and Prognosis of Heart Failure with Reduced Ejection Fraction in Women and Men in Sinus Rhythm. [PDF]

J Clin Med
Mansur AP, Bergamo ME, Nascimento GBD, Machado GS, Del Carlo CH, Avakian SD, Pereira-Barretto AC, Bocchi EA.   +7 more
europepmc   +1 more source

The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction

, 2016
Błażej Michalski, P. Trzcinski, Karolina Kupczyńska, Dawid Miśkowiec, Łukasz Pęczek, Barbara Nawrot, Piotr Lipiec, Jarosław D. Kasprzak   +7 more
openalex   +2 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings. [PDF]

Front Pharmacol
Asensio-Lopez MDC, Severino P, Lax A.
europepmc   +1 more source